We are using cookies in order to facilitate your navigation on this website. You can read about
how we use cookies and how to manage them here
. By continuing to navigate on this website or clicking on the button, you accept our
cookie notice
and related
Privacy Policy
.
I accept the use of cookies
Molecular Partners
Partnering
Careers
Contact Us
About Us
Our DARP
in
®
Platform
Our Approach
Pipeline
Investors
Share Information
Analyst Coverage
News Releases
Investor & Scientific Documents
General Meetings
Governance & Compliance
Financial Calendar & Events
Investor Contact
Register for Email News
News
Home
About Us
Our DARP
in
®
Platform
Our Approach
Pipeline
Investors
« Back
Investors
Share Information
Analyst Coverage
News Releases
Investor & Scientific Documents
General Meetings
Governance & Compliance
Financial Calendar & Events
Investor Contact
Register for Email News
News
Partnering
Careers
Contact Us
Pipeline
Pipeline
Our DARPin
®
engine is an unlimited source of novel therapeutic designs. Explore our pipeline:
Candidate / Focus
Research
Preclinical
Phase 1
Phase 2
Phase 3
Rights
Ensovibep (MP0420) / COVID-19
Preclinical
MP0423 / COVID-19
Preclinical
MP0310 / FAP x 4-1BB
Phase 1
MP0317 / FAP x CD-40
Preclinical
CD3 / T-Cell targeting DARPins
Preclinical
Peptide-MHC targeting DARPins
Research
MP0250 / Multiple myeloma / PI combo
Phase 2
MP0274 / HER2+ tumors
Phase 1
Abicipar / Neovascular AMD
Phase 3
Abicipar / DME
Phase 3